[1] 汪复, 朱德妹, 胡付品. 2012 年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗杂志, 2013, 13(5):321-330. [2] File TM, Srinivasan A, Bartlett JG. Antimicrobial stewardship:importance for patient and public health[J]. Clin Infect Dis, 2014, 59(suppl. 3):S93-S96. [3] Nelson DC, Schmelcher M, Rodriguez-Rubio L, et al. Endolysins as antimicrobials[J]. Adv Virus Res, 2012, 83:299-365. [4] 方圆子, 王琰, 孙建和. 噬菌体裂解酶——现状与未来[J]. 微生物学通报, 2009, 36(12):1888-1893. [5] Jun SY, Jung GM, Yoon SJ, et al. Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient[J]. Antimicrob Agents Chemother, 2014, 58(4):2084-2088. [6] Schmelcher M, Donovan DM, Loessner MJ. Bacteriophage endolysins as novel antimicrobials[J]. Future Microbiol, 2012, 7(10):1147-1171. [7] Wu HY, Lu HR, Huang JJ, et al. EnzyBase:a novel database for enzybiotic studies[J]. BMC Microbiol, 2012, 12(1):54. [8] 王铮, 沈文彬, 等. 噬菌体裂解酶作为抗菌药物的研究进展 [J]. 上海交通大学学报:医学版, 2013, 33(3):368-373. [9] Kunde S, Cloney D, Conrad H, et al. Fecal microbial transplantation shows efficacy in children with refractory ulcerative colitis-early results of phase I clinical trial:P-128[J]. Inflamm Bowel Dis, 2012, 18:S66-S67. [10] Saravanan SR, Paul VD, George S, et al. Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128:Comparison to recombinant lysostaphin[J]. Bacteriophage, 2013, 3(3):e26564. [11] Young R, Bläsi U. Holins:form and function in bacteriophage lysis[J]. Fems microbiol Rev, 1995, 17(1-2):195-205. [12] Briers Y, Volckaert G, et al. Muralytic activity and modular struct-ure of the endolysins of Pseudomonas aeruginosa bacteriophages φKZ and EL[J]. Mol Microbiol, 2007, 65(5):1334-1344. [13] Lu HR, Gu MG, et al. Hydrogen/deuterium exchange mass spectro-metry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains[J]. Antimicrob Agents Chemother, 2013, 4:1872-1881. [14] Lawrence R, Jeyakumar E. Antimicrobial resistance:a cause for global concern[J]. BMC Proceedings, 2013, 7(3):1-14. [15] 王琰, 陆承平. 噬菌体裂解酶的抗菌特性[J]. 微生物学报, 2009, 49(10):1277-1277. [16] 杨航, 余军平, 危宏平. 裂解酶治疗的研究进展与应用前景[J]. 微生物学通报, 2015, 42(1):178-184. [17] Dong Q, Wang J, Yang H, et al. Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci[J]. Microb Biotechnol, 2015, 8(2):210-220. [18] Daniel A, Euler C, Collin M, et al. Synergism between a novel chi- meric lysin and oxacillin protects against infection by methicillin- resistant Staphylococcus aureus[J]. Antimicrob Agents Chemo-ther, 2010, 54(4):1603-1612. [19] Donovan DM, Dong S, Garrett W, et al. Peptidoglycan hydrolase fusions maintain their parental specificities[J]. Appl Environ Microb, 2006, 72(4):2988-2996. [20] Pastagia M, Euler C, Chahales P, et al. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resi- stant and-sensitive Staphylococcus aureus strains[J]. Antimicro- b Agents Chemother, 2011, 55(2):738-744. [21] Schmelcher M, Tchang VS, et al. Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity[J]. Microb Biotechnol, 2011, 5:651-662. [22] Layec S, Decaris B, Leblond-Bourget N. Characterization of proteins belonging to the CHAP-related superfamily within the Firmicutes[J]. J Mol Microb Biotech, 2008, 14(1-3):31-40. [23] Rigden DJ, Jedrzejas MJ, Galperin MY. Amidase domains from bacterial and phage autolysins define a family of γ-D, L-glutamate-specific amidohydrolases[J]. Trends Biochem Sci, 2003, 28(5):230-234. [24] Filatova LY, Becker SC, et al. LysK, the enzyme lysing Staphyloco-ccus aureus cells:specific kinetic features and approaches towards stabilization[J]. Biochimie, 2010, 92(5):507-513. [25] 顾敬敏. 金黄色葡萄球菌噬菌体 GH15及其裂解酶三维结构与分子作用机制研究[D]. 长春:吉林大学, 2014. [26] 杨信怡, 游雪甫, 蒋建东. 溶葡萄球菌酶的抗菌活性研究进展[J]. 中国新药杂志, 2006, 14(9):1113-1117. [27] Mao J, Schmelcher M, Harty WJ, et al. Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme[J]. Fems Microbiol Lett, 2013, 342(1):30-36. [28] Koehl JL, Muthaiyan A, Jayaswal RK, et al. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2004, 48(10):3749-3757. [29] Yang H, Zhang Y, Yu J, et al. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo[J]. Antimicrob Agents Chemother, 2014, 58(1):536-542. [30] Filatova LY, Donovan DM, Becker SC, et al. An investigation of the structure and function of antistaphylococcal endolysins using kinetic methods[J]. Moscow Univ Chem Bull, 2014, 69(3):107-111. |